RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.68B
AUM Growth
-$184M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1 +$70.3M
2 +$46.2M
3 +$33.2M
4
SLDB icon
Solid Biosciences
SLDB
+$19.5M
5
KOD icon
Kodiak Sciences
KOD
+$14.7M

Top Sells

1 +$58.5M
2 +$28.3M
3 +$14.8M
4
AXSM icon
Axsome Therapeutics
AXSM
+$13.7M
5
XFOR icon
X4 Pharmaceuticals
XFOR
+$4.87M

Sector Composition

1 Healthcare 97.05%
2 Technology 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$398M 23.72%
4,132,442
2
$160M 9.51%
7,775,207
3
$158M 9.43%
9,724,598
4
$115M 6.85%
4,858,260
5
$90.5M 5.39%
2,260,751
-1,461,753
6
$77.8M 4.63%
2,162,671
7
$73.9M 4.4%
3,422,312
+1,537,530
8
$70.3M 4.19%
+4,681,858
9
$62.1M 3.7%
522,448
+11,615
10
$47.3M 2.82%
304,744
+125,448
11
$46.2M 2.75%
+3,987,560
12
$41.3M 2.46%
3,363,605
+619,980
13
$38.6M 2.3%
6,880,323
14
$35.8M 2.14%
1,663,512
-24,900
15
$35.3M 2.1%
2,456,669
16
$32.1M 1.91%
6,166,875
-378,767
17
$28.2M 1.68%
1,875,209
18
$24.1M 1.43%
1,119,963
19
$19.1M 1.14%
3,247,005
20
$17.3M 1.03%
90,840
21
$15.5M 0.92%
61,412
22
$14.7M 0.88%
+1,025,165
23
$14.4M 0.86%
1,000,000
24
$13.4M 0.8%
664,385
-676,443
25
$11.5M 0.69%
+429,399